Raisio plc

Hyvää keskipäivää. Tervetuloa seuraamaan Raision tilinvaihdostiedotetta vuodelta 2025. Kiitos, kun olette mukana. Vuosi 2025 oli meille ennen kaikkea tulostason vahvistamista ja kasvun edellytysten rakentamista. Tehtiin vuoden aikana selkeitä valintoja, jotka näkyy parempana tuloksena ja vahvempana valmiutena kasvuun. My name is Pasi Flitman and I am the CEO of RAISIO. The intention was that our financial manager Mika Saarinen would also be with us, who unfortunately could not participate due to a recent illness. We will now go through this short presentation together and after that I will answer any questions that may have been asked in the chat. So you should put it in there if you have any questions. In the fourth year, our turnover turned to small growth. At the same time, the continued strengthening of profitability continued throughout the year. Elovena continued to have a strong trend in Finland, and Benekon was also in small growth. In the UK market, of course, this good Puntamyynti leikkaantui jonkin verran sitten kun sitä käännettiin euroiksi valuuttakurssista johtuen. Pitkin vuotta meillä haasteena ollut business to business puolen lasku tasaantui ja korjaavat toimenpiteet alkaa näkyä ja tuomaan tulosta. Also, the transfer of plant proteins can be seen both on the top line and, above all, as an improvement in the results. In the last quarter of the year, we also saw the cost of the ERP project, the new project of the operations management system, which, for this quarter of the year, was about 0.4 million euros. At the annual level, the development of the industry remained our strategic goal. The background is especially the volume of domestic industrial sales and farmers' markets. In addition, the impact of plant proteins on about 4 million euros. Without the impact of plant protein sales, we were in very small growth as a whole. However, the most important thing about last year was that our turnover clearly improved, and the turnover increased by more than 20%. There are a lot of different factors behind this, and different enforcement activities. For example, the development of our different products and production in Kaura and the return of Penecol to the plant career. Also, the release of plant proteins clarified the whole thing and improved our income level. The income of the invested capital and the comparable income per share clearly improved. Our balance sheet is still very strong, which also allows us to carry out our strategy in the future. The flow of money decreased during the comparison period because we have completed our reserves in several main crop species. Last year's comparison level was very low and now the market prices were such that it is reasonable and reasonable to complete these reserves. This is a well-known choice, and it does not change the overall picture of our very strong financing position. Let's move on to the year 2026. We recommend that the turnover and the comparable turnover increase in the year 2025. The government recommends a 0.15 euro share of the share, which is a small increase to last year's 0.14 €, so a small rise to it. The share policy remains the same and the goal is to share 50-100% of this share-based income every year. Once again, a reminder of our reporting segments, which have been in use since last June and how our business activities are distributed. The purpose of this reminder is to make it easier for you to model and compare our operations. The main part of our continuous business activities, Breakfast, Snacking, Food Solutions and Heart Health business activities are reported as part of the Brands and Industrial segment. Other operations segment includes new business operations and business units serving individual and joint operations and concern management Let's now look at the Brands and Industrial segment, which is next So this was the majority of current business, including consumer and B2B business and the main market area of Europe the most well-known brands, Benegol and Lovera. Within the Brands and Industrial segment, we have two business units. Breakfast and Snacking Food Solutions' turnover increased by 4% in the last quarter of the year, and Heart Health Business Unity's turnover increased by 1.5%. Breakfast Snacking Food Solutions has a significant role in Finland, while the largest individual market area in Heart Health is Great Britain. The whole thing is quite balanced. Finland's consumer business is a strong supporting leg that is good to build on. At the same time, Heart Health brings internationality to us, and Food Solutions brings clear scale benefits and covers a lot of costs. Also, internationality and B2B business activities reduce our dependency on individual, large, domestic customers. In the last quarter of this year, the turnover of the Brands and Industrial segment increased by 2.7% and the turnover increased significantly faster, by more than 11%. Breakfast, snacking, food solutions. Breakfast, snacking, food solutions. Yksikössä liikevaihto tosiaan kasvoi myöskin jonkin verran, mutta tulos ei niinkään, koska me jatkettiin pitkäjänteisesti meidän panostuksia myyntiin ja markkinointiin ja se luo edellytykset sitten pitkän aikavälin kasvulle. Hiukan tarkemmin sitten näiden liiketoiminta-alueitten myynnin kehityksiä eri puolilta. Breakfast Snacking Food Solutions In the fourth year, trade growth increased by 4%. Finland's consumer sales increased. Food solutions became more stable. In other businesses, there is more exchange. Especially in the retail market, there is a lot of volatility. In the Food Solutions section, you can see the market prices of raw materials. Overall, the focus has been on profitability and competitiveness, and sales development and faster revenue improvement tell us about efficiency and better performance in everyday life. I would also like to note that even if it seems that these three parts, Finland's B2C, food solutions and others, are about the same size, but the scales in these pictures are different. In the Finnish consumer market, from 0 to 20 million, and in other parts, from 0 to 4 million. Finland is clearly larger than in the negative development. The other part is relatively small. In larger parts, performance was clearly stronger. On the other hand, the growth of heart health is 15.5%. Great Britain is reported to be at minus 1.5%. On the other hand, the sales growth was at 3%. The conversion of the currency here unfortunately affects negatively this time. In Finland, in small growth, in Ireland, very close to last year's level and then more changes in other markets In other markets, the change is especially brought by this industrial B2B sale, in which it is a normal swing from one cart to another, there is no drama related to it Sometimes a little better, sometimes a little lower Generally, a few comments from the market The market is starting to stabilize, but it is still a bit difficult to predict, as the world has usually prevented inflation pressures, but the overall question is still soft There is uncertainty about the world trade and tariffs. However, their impact on our business operations is quite limited. Consumption and trust are still quite low, and pricing and campaign weightlessness can be seen in buying. In particular, in products with a lower supply level, volume pressures are generally present in the market. At the same time, Megatrends have been supporting RISE's views for a long time. Our brands have shown that they are also trusted in uncertain times. The values ​​related to health and recovery continue clearly. When there is uncertainty in the market, consumers seek security. strong and well-known brands are doing the best, and Raisio has managed at least in the market phase or a little faster, a little to switch from the market to another. From the morning and afternoon markets, especially the Finnish domestic market, I could comment on the fact that the Päivittäistavarakauppeyhdistys, PTY, assessed their January-March sales increased by 2.4% for the entire market, and volumes stayed in the front line, so all of that has come from the rise in prices. At the same time, the growth of trade in RISE increased by 6%, and volume increased by 9%, so clearly the market is developing faster. In products that reduce cholesterol, Markkina on ollut maltillisessa kasvussa Euroopassa. Kokonaisuutena oltu markkina vauhdissa tai hiukan edellä. Suomessa edellä, Iso-Britanniassa, Irlannissa, aika lailla markkinamukaisessa vauhdissa. Puolassa meillä on ollut haasteita, eikä olla ihan pysytty markkinassa mukana, johtuen erityisesti tämän diskounterkanavan painotuksesta siellä markkinassa. As a recap, our strategic focus points. The biggest sources of organic growth are breakfast and lunch products, and also heart health products. So, Elowena and Benecol are still playing an important role. At the same time, the growth of the future is being built on the requirements for long-term growth as well. business opportunities through our own research activities and established business purchases. Our local traditional brands, plant-based industries and large kitchen solutions cover a lot of our costs and bring us a wealth of money to fund this growth. In other words, each business area has its own role, and we have also organized this support during the year. In addition, a few increases in the implementation of the strategy during the year 2025. We have continued to invest in the future. We have launched, for example, building a Nokia mill in many laboratory spaces, and increased capacity there. At Raisionmylli, the renovation of the pasta packaging plant, the construction of a product development plant, new R&D spaces have been launched, and then also the construction of our research and product development pilot institute at a high speed. We also invest in data management, different kinds of skill and also the largest project at the moment, the new ERP system, i.e. the business management system. In total, this project will take about a year and a half. It has started in the fall and supports our journey towards a stronger, more sustainable Raisio and also supports the implementation of our strategy. For example, the integration of corporate purchases is much easier in a cloud-based standard organization. We have also reorganized again during this year. We have improved our focus through it and can clearly see many improvements and improved performance. If I summarize three things in the end of 2025, The profitability has clearly improved, our focus has improved, and we are starting to look for growth in 2020-2026. We have a stronger income level, a clear direction, and we advise that this year we are looking for growth in both business changes and competitive business results. Finally, I would like to thank Thank you very much to all of the Raisijan members and our partners for their excellent cooperation during the year. Thank you also to the listeners. Now, if you have any questions, we will open them. Have we received any questions? Yes, we have received a few questions. The first one is whether the report mentions a decrease in license fees. Is a possible permanent loss due to a quarter? There are no permanent losses. It's quite a normal season change. There are no major permanent losses. There are actually more interesting opportunities and new opportunities to grow it. The second question is related to the action-guidance system project. Does ERP's Q4 impact also reflect the expected impact of the coming quarters? It is not necessarily the same for each quarter, but the whole class is probably right. is significantly different. The next question is, what kind of companies would RAISIO be interested in buying? This is divided into two main areas. The first is one with clear, direct links to our current business, either to Viljapohja's Aamupala, Välipala, breakfast and snacking activities or heart health, so synergistic activities that help them grow, support their growth or increase our share of the whole value chain. Those are the types of things that interest us, but we also look at the possibilities for us as a whole to have a new categories or segments, when it is part of our overall strategy. It is also possible that the purchase will face such a third support leg. There is room for play. First of all, the most important thing is that we can create value for our owners, both in the short and long term. And then there's one more question here. Is the recommended growth based on the development of both central business units? Are there clear differences in these views in the year 2026? Quite evenly, yes, we are looking for positive development from both. There may be small time differences, but I won't talk about that here. There was another question. How has the expansion of the sales of Eloveena advanced for new markets? We are not exactly... the speed at which we have set our goals. On the other hand, we have learned a lot of things, and the profitability of the expansion of business has also improved. Our prices have improved there, and we have changed some of the products, and the latest rotation figures, reports on how goods circulate, we have clearly advanced. We are not at full speed, but I believe that the model of operation, in which we are constantly looking for learning and checking our way of working, and we are constantly developing it, has accumulated the knowledge we need and leads to good results. Tässä oli kysymykset. Kiitoksia erityisen paljon hyvistä kysymyksistä. Kiitos, kun olette olleet mukana. Erinomaisen hyvää loppuviikkoa ja alkavaa vuotta tässä kaikille. Kiitos.